Anti-IL5 treatments in severe asthma by blood eosinophil thresholds: indirect treatment comparison

In the absence of head-to-head comparisons, this indirect treatment comparison provides clinically relevant, comparative information on the efficacy of licensed formulations of the three approved anti-IL5 pathway therapies in SEA by baseline blood eosinophil count. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2wT6qYg